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Coiled-coil tropomyosin, localized on actin filaments in virtually all eukary-
otic cells, serves as a gatekeeper regulating access of the motor protein
myosin and other actin-binding proteins onto the thin filament surface. In
order to form a continuous cable on thin filaments that is free of gaps, adjacent
tropomyosin molecules polymerize head-to-tail by means of a short (~9-10
residue) overlap. Thus to characterize the overlap structure, several labora-
tories have engineered peptides to mimic the N/C-terminal tropomyosin
association. The overlapping domains formed show a compact N-terminal
coiled-coil inserting into a partially opened C-terminal partner, where the
opposing coiled-coils at the overlap junction face each other at up to ~90
twist angles. Here, Molecular Dynamics simulations were carried out to deter-
mine constraints on the formation of the tropomyosin overlap complex and to
assess the amount of twisting exhibited by full-length tropomyosin when
bound to actin. With the exception of the last 20 to 40 C- and N-terminal
residues, we find that the average tropomyosin structure closely resembles a
"canonical" model proposed in the classic work of McLachlan and Stewart,
displaying perfectly symmetrical supercoil geometry matching theF-actin he-
lix with an integral number of coiled-coil turns, a coiled-coil helical pitch of
137 A˚, a superhelical pitch of 770 A˚, and no localized pseudo-rotation. Over
the middle 70% of tropomyosin, the average twisting of the coiled-coil devi-
ates only by 10 from the canonical model and the torsional freedom is very
small (std. dev. of 7). This small degree of twisting cannot yield the orthog-
onal N- and C-termini configuration observed experimentally. However, in
marked contrast, considerable coiled-coil unfolding, splaying and twisting
at N- and C-terminal ends is observed, providing the conformational plasticity
needed for head-to-tail nexus formation.
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Myosin S1 binds to pyrene labelled thin filaments in a calcium dependent
manner. When mixing an excess of S1 with thin filaments at low calcium the
transient is complex in form and requires a complete model of the regulated
binding to fit the data. Using the recently published Monte Carlo version of
the Mckillop & Geeves model (REF) we have now fitted a complete set of cal-
cium dependent myosin binding transients to thin filaments containing WT hu-
man tropomyosin with human cardiac troponin. In addition we have analysed
the data for 5 tropomyosin mutations carrying HCM (E175N, & E180G) or
DCM mutations (E54K , E40K and D230N) in one or both Tm chains of the
dimer. All transients can be well described by the model and for each case
the calcium dependent data can be described by a single set of parameters
with a change only in the apparent value and calcium dependence of KB (the
equilibrium constant between the blocked and closed states of the filament)
small secondary effects may be present in value of KT ( equilibrium between
closed and open states). For the HCM mutations the value of KB showed
enhanced calcium sensitivity with little change in the value of KB at high
and low calcium. In contrast, preliminary data for DCMmutations showed little
change in the calcium dependence of KB, but larger changes in the low calcium
value of KB. This could mean that the DCMmutations turn off the thin filament
more effectively. All other constants remain unchanged within experimental
error.
Supported by the Welcome Trust, NIH R01 AR048776 and Serbian Ministry of
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While it’s been reported that non-muscle myosin such as myosin V can be
regulated by Mg2þ, striated muscle myosin modulation by Mg2þ-concentra-tion dependency, especially in relation to thin filament components, has not
been well studied up to now. It has been suggested that ADP release (product
release) from myosin V is affected by Mg2þ concentration. Therefore, Mg2þ-
dependent modulation of striated muscle myosin ATPase was explored in the
presence of reconstituted muscle thin filament components, i.e. actin, tropo-
myosin and troponin. ATPase activity assays and Nuclear Magnetic Reso-
nance (NMR) spectroscopy were employed to understand the mechanisms
of ATP hydrolysis by striated muscle myosin and the role of Mg2þ in the
enzymatic activity. An NMR technique called Water Ligand-Observed
Gradient Spectroscopy (WaterLOGSY) was utilized to probe if the interaction
of myosin with ADP (one of the products resulted from ATP hydrolysis) is
different depending on Mg2þ concentration as well as the presence of muscle
thin filament components. Our WaterLOGSY data demonstrated that this
technique is a promising method to monitor ADP binding to myosin head
S1 even in the presence of actin filaments and that there was a change in
the appearance of peaks between with and without tropomyosin at a low
Mg2þ concentration. This set of results indicates that the way by which
myosin binds ADP is different depending on the states of thin filaments.
Moreover, actomyosin S1 ATPase rate decreased as Mg2þ concentration
increased. When tropomyosin was reconstituted in the thin filaments, the
ATPase rate decreased more rapidly compared with actomyosin alone. Thus
we conclude that Mg2þ plays an important role in striated muscle myosin
ATPase and that regulatory components such as tropomyosin modulate
Mg2þ dependency of myosin ATPase in the striated muscle.
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The use of novel calcium sensitizing agents in the treatment of heart disease
offers therapeutic value for patients suffering from a particularly prevalent
and recalcitrant condition, however the elusive mechanisms of action for these
drugs prevent increased and improved utilization of such agents clinically.
Ideally the calcium sensitizer impact on the thin filament could be monitored
directly in a physiologically relevant and dynamic way while still capturing
the molecular level mechanisms involved. With that aim a homo-FRET scheme
was developed which monitors the N-domain opening of the calcium binding
subunit of cardiac troponin (N-cTnC) by labeling with TAMRA at
cTnC(cys-13) and cTnC(cys-51). Using this novel FRET design the calcium
binding properties of reconstituted troponin and their deactivation kinetics
were measured in the presence of calcium sensitizers Levosimendan, Bepridil,
Pimobendan, and EMD-57033 at various levels of in vitro reconstitution. We
hypothesized that depending on the mechanism for each calcium sensitizer
the effects on cTnC calcium binding and deactivation kinetics would vary
based on the level of reconstitution. We expect that new insight into which
thin filament proteins are necessary for sensitizer action will yield a clearer pic-
ture of the molecular level mechanisms underlying cardiotonic action.
Although the study is currently ongoing preliminary results show significant
sensitization for all four drugs in reconstituted ternary troponin compared to
control and that this effect is abrogated in samples containing only cTnC and
cardiac troponin inhibitory subunit (cTnI). Deactivation kinetics show a
decreased transition rate for Levosimendan, Bepridil and Pimobendan but
not for EMD-57033 both at the ternary troponin level and at the cTnI-cTnC
level. Results from measurements with reconstituted thin filament preparation
will be also discussed.
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During cardiac thin filament activation, the N-domain of Ca2þ-binding car-
diac troponin C (N-cTnC) interacts with the actomyosin inhibitory troponin
I (cTnI) subunit, which concomitantly opens the cTnC N-domain and leads to
force generation. Recently, we used in situ steady state FRET measurements
based on N-cTnC opening to determine that strongly bound cross-bridges
(XBs) stabilize this Ca2þ-sensitizing N-cTnC-cTnI interaction. However,
the method was unable to determine how N-cTnC opening is affected by
